|
|
H2022/CTD9096/18210
|
EMPIGET-M 5/500MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9093/18639
|
EMPIGET-M 5/1000MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2024/CTD7976/16737
|
XENGLU-MET 5/1000MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9094/18648
|
EMPIGET-M 12.5/500MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9095/18417
|
EMPIGET-M 12.5/1000MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2020/CTD7974/16738
|
XENGLU-MET 12.5/500MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7975/16739
|
XENGLU-MET 12.5/1000MG TABLETS
|
EMPAGLIFLOZIN + METFORMIN HCL
|
SURGILINKS LTD
|
Registered
|
Details →
|